Article

CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia

2025-08-27

Abstract excerpt

There is a continued need for identification of novel disease drivers of acute myeloid leukemia as many patients experience relapse and have poor clinical outcomes. Analyses from our study and publicly available datasets predicted CEBPD as a novel tumor suppressor gene in acute myeloid leukemia. Consistent with the analyses, CEBPD knockdown experiments showed activation of MAPK signaling with concomitant increase...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5464017d-bba3-592c-bb05-977990c3bd1a
DOI: 10.1101/2025.08.25.670309

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaDOI 10.1101/2025.08.25.670309Read

CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment.Semantic proximity Read

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future DirectionsSemantic proximity Read

[Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].Semantic proximity Read

A regulatory element in the 3'-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.Semantic proximity Read

Mutations in the bZip region of the CEBPA gene: A novel prognostic factor in patients with acute myeloid leukemia.Semantic proximity Read

Loss of MBD2 attenuates MLL-AF9-driven leukemogenesis by suppressing the leukemic cell cycle via CDKN1CSemantic proximity Read

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemiaSemantic proximity Read

Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemiaSemantic proximity Read

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.Semantic proximity Read

The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genesSemantic proximity Read

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupSemantic proximity Read

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity.Semantic proximity Read